JB Chemicals receives USFDA approval for Atenolol Tablets

13 Dec 2017 Evaluate

JB Chemicals & Pharmaceuticals has received USFDA approval for its Supplementary Abbreviated New Drug Application (sANDA) for Atenolol Tablets USP 25 mg. 50 mg. and 100 mg. (anti-hypertensive) manufactured using Company’s own bulk drug (API). The company had initiated this change as a part of its plan to gradually backward integrate US formulations business. This approval is expected to boost company’s US sales.

The company could not commercialize this formulation earlier due to problems associated with external API supplier. This approval will help company supply these formulations with its own API. The company plans to commercialize this product in the next quarter. Currently, the market for this product in US is about $70 million. The company is focused on US business and this approval will help grow its exports.

JB Chemicals & Pharmaceuticals (JBCPL) is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).



JB Chem & Pharma Share Price

1823.95 0.85 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×